Avelox 400 mg/250 ml inf. sol. i.v. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Moxifloxacin Hydrochloride 1,75 mg/ml - Eq. Moxifloxacin 1,6 mg/ml
Available from:
Bayer SA-NV
ATC code:
J01MA14
Pharmaceutical form:
Solution for infusion
Administration route:
Intravenous use
Therapeutic area:
Moxifloxacin
Product summary:
CTI Extended: 241613-02; 241613-01
Authorization status:
Commercialised: Yes
Authorization date:
2002-12-09
